SOURCE: StockCall


July 27, 2012 08:20 ET

Equity Research on WellPoint Inc. and CIGNA Corp. - Tough Times for Insurers

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jul 27, 2012) - offers free research on WellPoint Inc. (NYSE: WLP) and CIGNA Corp. (NYSE: CI) from the Health Care Plans industry. Access these reports by clicking on the links below or by copy and pasting those to your address bar.

Rising care prices continue to drive expenses up for most health care plan providers making profitability an even tougher task. Renewed concerns in Europe sent many investors running from equities, bringing share prices of several insurers down as well. is an online platform where investors doing their due-diligence on the Health Care Plans industry can have easy and free access to our analyst research and opinions on WellPoint Inc. and CIGNA Corp. To see how companies in this industry have grown over the past years and how they are expected to perform in the future, please visit the link below.

Growing domestic enrollment has also been difficult, further compounding the industry's existing growth obstacles. Overseas markets may begin to play an increasingly important role if domestic operations continue to stagnate. Cigna Corp.'s recently announced joint venture with Finansbank to sell insurance products in Turkey is even more encouraging considering the current outlook for the U.S. market. Register now to have free access to our report on CIGNA Corp., and to do so please click the link below.

Regulatory concerns never seem to go away for the industry, and now it's no different. It is been a month since the Supreme Court upheld most of President Obama's plan and the effects are coming into focus. Insurers weighted towards the individual and employer sponsored insurance market like WellPoint Inc. could be at greater risk to be affected by fees and restrictions imposed by the law. Investors and shareholders of WellPoint Inc. can simply register for our complimentary reports by clicking on the link below.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information